XIAP and urinary bladder carcinoma: The important role of the Smac/XIAP rheostat was demonstrated in pancreatic and bladder cancer by using small molecule inhibitors for XIAP as well as Smac mimetics, which both enhanced TRAIL sensitivity [90,91].